P

PathAI

371 employees

PathAI is developing technology that assists pathologists in making rapid and accurate diagnoses for every patient, every time.

Basic info

Industry

software development

Sectors

Biotechnology
computational pathology
pathology
neurodegenerative disease
solutions
predictive
improving medicine
auto immune disease
artificial intelligence
oncology
Health Diagnostics
R&D
deep learning
Health Care
digital pathology
precision medicine
software engineering
immuno-oncology
companion diagnostics

Date founded

2016

Funding rounds raised

Total raised

$165M

from 24 investors over 24 rounds

P

PathAI raised $165M on May 18, 2021

Investors: D1 Capital Partners L.P., Kaiser Permanente, General Catalyst, Polaris Partners, Bristol-Myers Squibb, UK, General Atlantic, KdT Ventures and Refactor Capital

P

PathAI raised $15M on November 4, 2019

Investors: Labcorp and Bristol-Myers Squibb, UK

P

PathAI raised $60M on April 17, 2019

Investors: Innospark Ventures, General Atlantic and General Catalyst

P

PathAI raised $11M on November 3, 2017

Investors: Refactor Capital, General Catalyst, KdT Ventures, 8VC, Pillar VC and DHVC

P

PathAI raised $4.2M on December 6, 2016

Investors: 8VC, DHVC, Refactor Capital, Fairhaven Capital and Pillar VC

FAQ